AmplifEYE assisted colonoscopy versus standard colonoscopy: A randomized controlled study
- PMID: 33141979
- DOI: 10.1111/jgh.15331
AmplifEYE assisted colonoscopy versus standard colonoscopy: A randomized controlled study
Abstract
Background and aim: AmplifEYE is a mucosal exposure device mounted to the tip of colonoscope to improve polyp or adenoma detection. We aim to compare the adenoma detection rates (ADR) of AmplifEYE-assisted colonoscopy (AC) with standard colonoscopy (SC).
Methods: We performed a randomized controlled trial involving patients aged 50 to 79 who underwent AC or SC in two centers. Procedures were performed by five experienced colonoscopists.
Results: Three hundred fifty-five patients were recruited, with 334 patients (170 AC and 164 SC) included into analysis. The ADR was numerically higher in AC (47.1%) versus SC (40.9%), P = 0.253. The polyp detection rate (PDR) in AC was 68.2% versus 54.3% in SC, P = 0.009, and serrated polyp detection rate (SDR) in AC was 37.6% versus 20.1% in SC, P < 0.001, both statistically significant higher in the study group. The mean cecal intubation time was shorter with AmplifEYE (8.0 min in AC vs 8.9 min in SC, P = 0.030), and there was no difference in pain score (3 in AC vs 4 in SC, P = 0.121).
Conclusions: AmplifEYE-assisted colonoscopy significantly improved the PDR and SDR, while the ADR was numerically higher in AC that did not reach statistical significance. Using the device resulted in shorter cecal intubation time and did not cause more pain.
Keywords: adenoma detection rate; colonoscopy; colorectal cancer screening; mucosal exposure device; polyp detection rate.
© 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
References
-
- Bray F, Ferlay J, Soerjomatarm I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018; 68: 394-424.
-
- Nishihara R, Wu K, Lochhead P et al. Long term colorectal-cancer incidence and mortality after lower endoscopy. N. Engl. J. Med. 2013; 369: 1095-1105.
-
- Rex DK, Cutler CS, Lemmel GT et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112: 24-28.
-
- Corley DA, Jensen CD, Marks AR et al. Adenoma detection rate and risk of colorectal cancer and death. N. Engl. J. Med. 2014; 370: 1298-1306.
-
- Kaminski MF, Regula J, Kraszewska E et al. Quality indicators for colonoscopy and the risk of interval cancer. N. Engl. J. Med. 2010; 362: 1795-1803.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials